Department of Nephrology and Hypertension, University Medical Center Utrecht, Regenerative Medicine Center-Hubrecht Institute, Utrecht, the Netherlands
Auto-generated profile, based on publicly available information
Rachel H. Giles
Department of Nephrology and Hypertension, University Medical Center Utrecht, Regenerative Medicine Center-Hubrecht Institute, Utrecht, the Netherlands
THE Rubinstein-Taybi syndrome (RTS) is a well-defined syndrome with facial abnormalities, broad thumbs, broad big toes and mental retardation as the main clinical features1-3. Many patients with RTS have been shown to have breakpoints in, and microdeletions of, chromosome 16pl3.3 (refs 4-8). Here we report that all these breakpoints are restricted to a region that contains the gene for the human CREB binding protein (CBP), a nuclear protein participating as a co-activator in cyclic-A IMP-regulated gene expression9-12. We show that RTS results not only from gross chromosomal rearrangements of chromosome 16p, but also from point mutations in the CBP gene itself. Because the patients are heterozygous for the mutations, we propose that the loss of one functional copy of the CBP gene underlies the developmental abnormalities in RTS and possibly the propensity for malignancy.
1 June 2003 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer